Stay Updated
For all press requests, please reach out to [email protected].
News and Reports
STAT News: Court ruling allows Medicare to negotiate prices for larger number of drugs
The drug industry has been on a losing streak on this issue, at least in the courtroom. Judges have ruled against pharmaceutical companies at least 15 times since the law governing negotiations went into effect in 2023, according to Patients for Affordable Drugs, which supports letting Medicare negotiate lower drug prices. In its cases, the industry […]
News and Reports
Kerrigan and McCullough are part of Patients for Affordable Drugs, a national organization dedicated to lowering prescription drug prices.
News and Reports
Sarah Wisniewski, a Maryland resident in her mid-40s, has been living with multiple sclerosis since 2018. Although she she says she has good insurance, it has repeatedly failed to cover the specialty medication her doctor prescribed to slow the progression of her disease. In 2024, when her physician recommended a treatment that could help, she […]
News and Reports
Epoch Times: $17,000 per Month: How Sky-High Prescription Prices Take Toll on Patients
However, advocacy group Patients for Affordable Drugs calls it an effort to prevent Medicare from negotiating prices on commonly used drugs.
News and Reports
Advisory Board: Around the nation: Pfizer enters the obesity care market with Metsera acquisition
Several other drugmakers and trade groups have filed lawsuits against Medicare drug price negotiation, but they have been consistently shot down in federal court, with judges ruling that the law is not unconstitutional. “After 14 courtroom defeats to date, this latest appeal is just another attempt by the industry to restrict the government’s power to […]
News and Reports
Oprah Daily: What New Drug Tariffs Could Mean for Menopause Care
Unfortunately, experts say that these tariffs will likely raise expenses for patients, disrupt global supply chains, and create drug shortages. “The reality is that patients feel the pain of tariffs long before any potential benefits materialize,” says Merith Basey, the executive director of Patients for Affordable Drugs. “And history shows that drugmakers will simply pass […]
News and Reports
STAT News: Hill staff get briefed on implications of Trump’s drug pricing plan
“There is bipartisan momentum,” said Merith Basey, executive director of Patients for Affordable Drugs, which brought advocates to the Hill last week for meetings with Republicans and Democrats alike. “We are doubling down. Our patients are here for the long haul.”
News and Reports
Inside Health Policy: Third Circuit Unanimously Rejects Novartis’ Claims Against IRA
“Big pharma’s legal arguments against the Medicare Negotiation Program continue to prove baseless, and their high-priced lawyers have once again lost in court. With the first round of lower negotiated prices set to take effect in January, and the second round of drugs to be announced in the coming weeks, more than 9 million patients […]